[Dystonia as the cause of pharyngolaryngeal motility disorders].
Dystonia as cause of pharyngo-laryngeal motility disorders has not been adequately considered in most clinical ENT practices. This case study of a patient with spasmodic torticollis, Meige's syndrome and pharyngo-laryngeal motility disorder was found to be due to dystonia as the underlying cause. The possibility of local symptomatic therapy with botulinum toxin injections has currently provided the physician with an effective means for alleviating the disorder.
Zwirner
P
P
Abteilung Phoniatrie und Pädaudiologie, Universität Göttingen.
Dressler
D
D
D001905:Botulinum Toxins / Q000008:administration & dosage / Q000009:adverse effects; D004421:Dystonia / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D004576:Electromyography; D006801:Humans; D007273:Injections, Intramuscular; D007818:Laryngeal Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D007828:Laryngoscopy; D008297:Male; D008538:Meige Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D008875:Middle Aged; D009334:Neck Muscles / Q000187:drug effects / Q000503:physiopathology; D010608:Pharyngeal Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D012131:Respiratory Insufficiency / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D014103:Torticollis / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D014827:Vocal Cords / Q000187:drug effects / Q000503:physiopathology
D001905:Botulinum Toxins